Foscarnet and Ibalizumab : 2021 abstract @ AIDS
Post# of 148679
(Total Views: 543)
Posted On: 10/13/2024 12:52:38 AM
Foscarnet and Ibalizumab :
2021 abstract @ AIDS conference pdf paper, reported efficacy against each other.
We know Foscarnet is Dr. Lataillade.
____
"2016, Ibalizumab (IBA) is the first long-acting monoclonal antibody HIV-1 entry inhibitor in Phase 3 development for treatment of MDR HIV. IBA was granted Orphan Drug status and Breakthrough Therapy designation by the FDA."
& author name ring a bell?
https://academic.oup.com/ofid/article/3/suppl_1/LB-6/2637742
2021 abstract @ AIDS conference pdf paper, reported efficacy against each other.
We know Foscarnet is Dr. Lataillade.
____
"2016, Ibalizumab (IBA) is the first long-acting monoclonal antibody HIV-1 entry inhibitor in Phase 3 development for treatment of MDR HIV. IBA was granted Orphan Drug status and Breakthrough Therapy designation by the FDA."
& author name ring a bell?
https://academic.oup.com/ofid/article/3/suppl_1/LB-6/2637742
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼